13D/13G Filings - Lyell Immunopharma Inc. (LYEL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
4:04 pm
Purchase
2025-03-3113GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV, L.P.1,358,095
9.200%
384,150increase
(+39.44%)
Filing
History
2025-02-14
4:55 pm
Purchase
2024-12-3113GLyell Immunopharma, Inc.
LYEL
ARCH Venture Fund IX, L.P.1,829,886
13.100%
6,000increase
(+0.33%)
Filing
History
2025-02-14
2:20 pm
Purchase
2024-12-3113GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV, L.P.973,945
6.700%
289,752increase
(+42.35%)
Filing
History
2025-02-05
1:23 pm
Sale
2024-12-3113GLyell Immunopharma, Inc.
LYEL
BlackRock Inc.
BLK
663,293
4.500%
-51,818decrease
(-7.25%)
Filing
History
2024-11-12
4:04 pm
Unchanged
2024-09-3013GLyell Immunopharma, Inc.
LYEL
The Vanguard Group503,574
3.930%
0
(Unchanged)
Filing
History
2024-11-04
1:30 pm
Sale
2024-09-3013GLyell Immunopharma, Inc.
LYEL
The Vanguard Group503,574
3.930%
-176,627decrease
(-25.97%)
Filing
History
2024-10-31
6:00 pm
Purchase
2024-10-2513GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV, L.P.684,193
5.300%
184,193increase
(+36.84%)
Filing
History
2024-02-14
3:18 pm
Purchase
2023-12-3113GLyell Immunopharma, Inc.
LYEL
ARCH Venture Fund IX, L.P.1,823,886
14.500%
3,250increase
(+0.18%)
Filing
History
2024-02-13
5:08 pm
Purchase
2023-12-2913GLyell Immunopharma, Inc.
LYEL
The Vanguard Group680,201
5.400%
50,640increase
(+8.04%)
Filing
History
2024-01-29
5:25 pm
Purchase
2023-12-3113GLyell Immunopharma, Inc.
LYEL
BlackRock Inc.
BLK
715,111
5.700%
715,111increase
(New Position)
Filing
History
2023-02-13
5:02 pm
Sale
2022-12-3113GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV, L.P.500,000
4.000%
-164,109decrease
(-24.71%)
Filing
History
2023-02-09
11:25 am
Purchase
2022-12-3013GLyell Immunopharma, Inc.
LYEL
The Vanguard Group629,562
5.050%
629,562increase
(New Position)
Filing
History
2022-02-14
4:17 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
MWG Management Ltd.1,008,117
8.380%
1,008,117increase
(New Position)
Filing
History
2022-02-14
4:10 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
NEWTON (PTC) Ltd754,698
6.280%
754,698increase
(New Position)
Filing
History
2022-02-14
12:04 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
ARCH Venture Fund IX, L.P.1,820,636
15.100%
1,820,636increase
(New Position)
Filing
History
2022-02-11
3:10 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV, L.P.664,109
5.500%
664,109increase
(New Position)
Filing
History
2022-02-10
4:51 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
GSK PLC1,512,659
12.600%
1,512,659increase
(New Position)
Filing
History